

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.71543666 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.03137131 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.03137131 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 4.94187147 |
| 5 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.73536750 |
| 6 | proteasome assembly (GO:0043248) | 4.55537935 |
| 7 | oxidative phosphorylation (GO:0006119) | 4.50177367 |
| 8 | cullin deneddylation (GO:0010388) | 4.43596630 |
| 9 | reactive oxygen species biosynthetic process (GO:1903409) | 4.15695824 |
| 10 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.05690694 |
| 11 | ribosomal large subunit biogenesis (GO:0042273) | 4.03011478 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.00077676 |
| 13 | protein deneddylation (GO:0000338) | 3.98156370 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.93432526 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 3.92419883 |
| 16 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.91971524 |
| 17 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.87989551 |
| 18 | protein complex biogenesis (GO:0070271) | 3.83268180 |
| 19 | respiratory electron transport chain (GO:0022904) | 3.80546794 |
| 20 | low-density lipoprotein particle clearance (GO:0034383) | 3.74519148 |
| 21 | response to peptidoglycan (GO:0032494) | 3.73010977 |
| 22 | respiratory burst (GO:0045730) | 3.72870476 |
| 23 | ribosomal small subunit assembly (GO:0000028) | 3.72235295 |
| 24 | electron transport chain (GO:0022900) | 3.70816111 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.69367582 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67075577 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67075577 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.67075577 |
| 29 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67075577 |
| 30 | modulation by symbiont of host defense response (GO:0052031) | 3.67075577 |
| 31 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67075577 |
| 32 | protein neddylation (GO:0045116) | 3.65570151 |
| 33 | CENP-A containing nucleosome assembly (GO:0034080) | 3.65315231 |
| 34 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.64179549 |
| 35 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.60009458 |
| 36 | NADH dehydrogenase complex assembly (GO:0010257) | 3.60009458 |
| 37 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.60009458 |
| 38 | chromatin remodeling at centromere (GO:0031055) | 3.56412603 |
| 39 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.55709883 |
| 40 | cotranslational protein targeting to membrane (GO:0006613) | 3.53358079 |
| 41 | superoxide anion generation (GO:0042554) | 3.51402366 |
| 42 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.51320658 |
| 43 | organelle disassembly (GO:1903008) | 3.48015988 |
| 44 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.46367457 |
| 45 | natural killer cell mediated immunity (GO:0002228) | 3.46367457 |
| 46 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.45578673 |
| 47 | DNA ligation (GO:0006266) | 3.43380763 |
| 48 | protein targeting to ER (GO:0045047) | 3.42138824 |
| 49 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.37821084 |
| 50 | respiratory chain complex IV assembly (GO:0008535) | 3.33428002 |
| 51 | * aldehyde catabolic process (GO:0046185) | 3.33420415 |
| 52 | protein localization to endoplasmic reticulum (GO:0070972) | 3.32582580 |
| 53 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.31873622 |
| 54 | establishment of integrated proviral latency (GO:0075713) | 3.30147950 |
| 55 | regulation of chemokine biosynthetic process (GO:0045073) | 3.26844130 |
| 56 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.26481091 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 3.26120209 |
| 58 | intraciliary transport (GO:0042073) | 3.25198521 |
| 59 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.19470980 |
| 60 | ribonucleoprotein complex disassembly (GO:0032988) | 3.19276242 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.17730247 |
| 62 | translational termination (GO:0006415) | 3.17582831 |
| 63 | chaperone-mediated protein transport (GO:0072321) | 3.15844774 |
| 64 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.13807567 |
| 65 | viral transcription (GO:0019083) | 3.12380033 |
| 66 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.12071538 |
| 67 | purine nucleobase biosynthetic process (GO:0009113) | 3.10568802 |
| 68 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.09891534 |
| 69 | branched-chain amino acid catabolic process (GO:0009083) | 3.09350260 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 3.09287411 |
| 71 | plasma lipoprotein particle clearance (GO:0034381) | 3.05675085 |
| 72 | wound healing, spreading of epidermal cells (GO:0035313) | 3.05417852 |
| 73 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05389086 |
| 74 | granulocyte activation (GO:0036230) | 3.04032372 |
| 75 | translation (GO:0006412) | 3.02930020 |
| 76 | formation of translation preinitiation complex (GO:0001731) | 3.00448559 |
| 77 | cysteine metabolic process (GO:0006534) | 2.99352693 |
| 78 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.99166137 |
| 79 | myeloid cell homeostasis (GO:0002262) | 2.98714364 |
| 80 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.98654213 |
| 81 | cytochrome complex assembly (GO:0017004) | 2.98552474 |
| 82 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.97656716 |
| 83 | cofactor catabolic process (GO:0051187) | 2.97329953 |
| 84 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.96356203 |
| 85 | aerobic respiration (GO:0009060) | 2.95070509 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.94907869 |
| 87 | hydrogen peroxide metabolic process (GO:0042743) | 2.94283434 |
| 88 | cellular response to interferon-alpha (GO:0035457) | 2.94163617 |
| 89 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.92845463 |
| 90 | ATP biosynthetic process (GO:0006754) | 2.91612397 |
| 91 | glucuronate metabolic process (GO:0019585) | 2.90624314 |
| 92 | uronic acid metabolic process (GO:0006063) | 2.90624314 |
| 93 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.90480637 |
| 94 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88263284 |
| 95 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.87859426 |
| 96 | negative regulation of ligase activity (GO:0051352) | 2.87859426 |
| 97 | regulation of mitochondrial translation (GO:0070129) | 2.87351052 |
| 98 | GTP biosynthetic process (GO:0006183) | 2.86896730 |
| 99 | DNA double-strand break processing (GO:0000729) | 2.86338861 |
| 100 | translational initiation (GO:0006413) | 2.86144885 |
| 101 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84902375 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.84630158 |
| 103 | protein carboxylation (GO:0018214) | 2.84630158 |
| 104 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.83350573 |
| 105 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.83350573 |
| 106 | eosinophil chemotaxis (GO:0048245) | 2.82714542 |
| 107 | cellular respiration (GO:0045333) | 2.81521284 |
| 108 | translational elongation (GO:0006414) | 2.80923000 |
| 109 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80690691 |
| 110 | DNA damage response, detection of DNA damage (GO:0042769) | 2.80010997 |
| 111 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.79315690 |
| 112 | histone exchange (GO:0043486) | 2.78467954 |
| 113 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.77975993 |
| 114 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.77975993 |
| 115 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.77975993 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.76897400 |
| 117 | response to interferon-alpha (GO:0035455) | 2.76592204 |
| 118 | neutrophil activation (GO:0042119) | 2.75890789 |
| 119 | L-ascorbic acid metabolic process (GO:0019852) | 2.75703243 |
| 120 | cellular response to superoxide (GO:0071451) | 2.75348942 |
| 121 | cellular response to oxygen radical (GO:0071450) | 2.75348942 |
| 122 | removal of superoxide radicals (GO:0019430) | 2.75348942 |
| 123 | peptidyl-histidine modification (GO:0018202) | 2.75254252 |
| 124 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.75233988 |
| 125 | platelet dense granule organization (GO:0060155) | 2.74748952 |
| 126 | DNA replication-independent nucleosome organization (GO:0034724) | 2.73874560 |
| 127 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.73874560 |
| 128 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.73515709 |
| 129 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.73515709 |
| 130 | fibrinolysis (GO:0042730) | 2.72151186 |
| 131 | lactate metabolic process (GO:0006089) | 2.72037627 |
| 132 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.69845225 |
| 133 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.69713106 |
| 134 | regulation of cholesterol storage (GO:0010885) | 2.69090954 |
| 135 | kinetochore organization (GO:0051383) | 2.69071041 |
| 136 | replication fork processing (GO:0031297) | 2.67548458 |
| 137 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.66192367 |
| 138 | kinetochore assembly (GO:0051382) | 2.65961525 |
| 139 | positive regulation of blood coagulation (GO:0030194) | 2.65593562 |
| 140 | positive regulation of hemostasis (GO:1900048) | 2.65593562 |
| 141 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.65043025 |
| 142 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.65043025 |
| 143 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.64408312 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.62954704 |
| 145 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.62413939 |
| 146 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.62413939 |
| 147 | positive regulation of ligase activity (GO:0051351) | 2.61663963 |
| 148 | anterograde synaptic vesicle transport (GO:0048490) | 2.60731079 |
| 149 | protein targeting to mitochondrion (GO:0006626) | 2.60627325 |
| 150 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.59105278 |
| 151 | hydrogen peroxide catabolic process (GO:0042744) | 2.58962467 |
| 152 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.58709554 |
| 153 | resolution of meiotic recombination intermediates (GO:0000712) | 2.58009938 |
| 154 | positive regulation of coagulation (GO:0050820) | 2.56895819 |
| 155 | B cell mediated immunity (GO:0019724) | 2.56850853 |
| 156 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.56282435 |
| 157 | positive regulation of mitochondrial fission (GO:0090141) | 2.56068090 |
| 158 | nucleobase biosynthetic process (GO:0046112) | 2.55492486 |
| 159 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.54546387 |
| 160 | positive regulation of heat generation (GO:0031652) | 2.54535592 |
| 161 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.54507367 |
| 162 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.53800940 |
| 163 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.53322347 |
| 164 | detection of molecule of bacterial origin (GO:0032490) | 2.53274626 |
| 165 | response to host immune response (GO:0052572) | 2.52736352 |
| 166 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.52736352 |
| 167 | acute-phase response (GO:0006953) | 2.50697279 |
| 168 | phagosome maturation (GO:0090382) | 2.50356365 |
| 169 | eosinophil migration (GO:0072677) | 2.50323750 |
| 170 | positive regulation of chemokine production (GO:0032722) | 2.49633393 |
| 171 | cellular glucuronidation (GO:0052695) | 2.48837597 |
| 172 | positive regulation of interferon-beta production (GO:0032728) | 2.48783324 |
| 173 | regulation of fever generation (GO:0031620) | 2.48583520 |
| 174 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.47806346 |
| 175 | L-phenylalanine metabolic process (GO:0006558) | 2.47806346 |
| 176 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.43943624 |
| 177 | monocyte chemotaxis (GO:0002548) | 2.43748782 |
| 178 | negative regulation of mast cell activation (GO:0033004) | 2.43452926 |
| 179 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.43301098 |
| 180 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.42438514 |
| 181 | superoxide metabolic process (GO:0006801) | 2.41554348 |
| 182 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.41294548 |
| 183 | negative regulation of viral genome replication (GO:0045071) | 2.40870945 |
| 184 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.40867491 |
| 185 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.40233145 |
| 186 | aromatic amino acid family catabolic process (GO:0009074) | 2.39319370 |
| 187 | mitochondrial calcium ion transport (GO:0006851) | 2.38799959 |
| 188 | L-phenylalanine catabolic process (GO:0006559) | 2.38733122 |
| 189 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.38733122 |
| 190 | glyoxylate metabolic process (GO:0046487) | 2.38552388 |
| 191 | cell adhesion mediated by integrin (GO:0033627) | 2.38417568 |
| 192 | response to interferon-beta (GO:0035456) | 2.38217861 |
| 193 | negative regulation of lipid storage (GO:0010888) | 2.38123747 |
| 194 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.34723048 |
| 195 | xenobiotic catabolic process (GO:0042178) | 2.33386946 |
| 196 | positive regulation of interleukin-6 production (GO:0032755) | 2.32943531 |
| 197 | indole-containing compound catabolic process (GO:0042436) | 2.32496291 |
| 198 | indolalkylamine catabolic process (GO:0046218) | 2.32496291 |
| 199 | tryptophan catabolic process (GO:0006569) | 2.32496291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.10527697 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.07010285 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.52911633 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.42455496 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.64752755 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.58206078 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.21665655 |
| 8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.20606679 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.06730982 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.06442210 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.04676925 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.97147959 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.95798767 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.91543981 |
| 15 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.89965889 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.89061352 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.87969867 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.82918635 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.81148460 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.73425059 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.72950580 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71771420 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68815819 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66980443 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.63181912 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.54422548 |
| 27 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.52472387 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.47235754 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.45730587 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43692017 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.35235671 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.30703173 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.30416266 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.22713565 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 2.18403255 |
| 36 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18079131 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15002208 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 2.12014136 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.07994274 |
| 40 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.05529169 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.05328630 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.04215352 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99844841 |
| 44 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98193400 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97199914 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97067175 |
| 47 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.92262346 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89073216 |
| 49 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.87438681 |
| 50 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.87048972 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86601236 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.86159159 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.85642153 |
| 54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.84877997 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84806557 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84102266 |
| 57 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.83951420 |
| 58 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.79205774 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75560632 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.74941397 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.73040791 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.71169066 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.69664891 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68172085 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65230286 |
| 66 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.63420578 |
| 67 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.62173328 |
| 68 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.62173328 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.60414772 |
| 70 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.60003012 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57966604 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57258397 |
| 73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.57231895 |
| 74 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57012535 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56606187 |
| 76 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55567841 |
| 77 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55081298 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53688603 |
| 79 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51083326 |
| 80 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50944912 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48867236 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.43592407 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42520977 |
| 84 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42291237 |
| 85 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.40732679 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.38837611 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37827402 |
| 88 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.37638998 |
| 89 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37150949 |
| 90 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36453624 |
| 91 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36241656 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34762670 |
| 93 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34700405 |
| 94 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.34291912 |
| 95 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33838040 |
| 96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32713118 |
| 97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31983076 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31609585 |
| 99 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27931394 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27181128 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26993665 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26504872 |
| 103 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26241383 |
| 104 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.25374491 |
| 105 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23892344 |
| 106 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23709944 |
| 107 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.21328685 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20590191 |
| 109 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20423790 |
| 110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.20099046 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19477193 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.19162781 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18767888 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18734549 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18182831 |
| 116 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16865566 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16389324 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16389324 |
| 119 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16121165 |
| 120 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15321284 |
| 121 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14052604 |
| 122 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14032233 |
| 123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12940195 |
| 124 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12059856 |
| 125 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12002931 |
| 126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11378860 |
| 127 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09975778 |
| 128 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.09421344 |
| 129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09117873 |
| 130 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08143533 |
| 131 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.07313836 |
| 132 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.04041206 |
| 133 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.03350595 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03315281 |
| 135 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03101477 |
| 136 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.03064416 |
| 137 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02577394 |
| 138 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.01514050 |
| 139 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00771022 |
| 140 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00422807 |
| 141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99765333 |
| 142 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99742103 |
| 143 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.97193582 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.97193582 |
| 145 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97122301 |
| 146 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96098646 |
| 147 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.95447324 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95341171 |
| 149 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.94634016 |
| 150 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94324693 |
| 151 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94251322 |
| 152 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94139270 |
| 153 | * HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.93980172 |
| 154 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93849787 |
| 155 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93842611 |
| 156 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93355379 |
| 157 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93086807 |
| 158 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92636521 |
| 159 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92473410 |
| 160 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92403786 |
| 161 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92255900 |
| 162 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.91724216 |
| 163 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91436373 |
| 164 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90024535 |
| 165 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.89731673 |
| 166 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89572648 |
| 167 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89543215 |
| 168 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88583677 |
| 169 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88583677 |
| 170 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.87225990 |
| 171 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.86359904 |
| 172 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86281920 |
| 173 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85675072 |
| 174 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85513411 |
| 175 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.84339888 |
| 176 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84077253 |
| 177 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.83929952 |
| 178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83639297 |
| 179 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83569757 |
| 180 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83403358 |
| 181 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83313058 |
| 182 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82977373 |
| 183 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80638181 |
| 184 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79981389 |
| 185 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79835246 |
| 186 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79261623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001529_abnormal_vocalization | 3.47679297 |
| 2 | MP0005360_urolithiasis | 3.40930899 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.26839936 |
| 4 | MP0003436_decreased_susceptibility_to | 3.23144541 |
| 5 | MP0009785_altered_susceptibility_to | 3.07407075 |
| 6 | MP0003195_calcinosis | 3.01395571 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.97254173 |
| 8 | MP0008058_abnormal_DNA_repair | 2.85089701 |
| 9 | MP0002938_white_spotting | 2.83594392 |
| 10 | MP0003186_abnormal_redox_activity | 2.83148116 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.82486723 |
| 12 | MP0004147_increased_porphyrin_level | 2.80991318 |
| 13 | MP0006082_CNS_inflammation | 2.74874441 |
| 14 | MP0003724_increased_susceptibility_to | 2.63077463 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.61950500 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.60270848 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.58654433 |
| 18 | MP0006072_abnormal_retinal_apoptosis | 2.55718698 |
| 19 | MP0008789_abnormal_olfactory_epithelium | 2.48050927 |
| 20 | MP0010094_abnormal_chromosome_stability | 2.44430549 |
| 21 | MP0002419_abnormal_innate_immunity | 2.37275980 |
| 22 | MP0003303_peritoneal_inflammation | 2.31849416 |
| 23 | MP0003880_abnormal_central_pattern | 2.28014722 |
| 24 | MP0006292_abnormal_olfactory_placode | 2.19843943 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 2.16185386 |
| 26 | MP0005025_abnormal_response_to | 2.11923130 |
| 27 | MP0003122_maternal_imprinting | 2.11479022 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.09715849 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 2.09232090 |
| 30 | MP0005085_abnormal_gallbladder_physiolo | 2.07157554 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06661099 |
| 32 | MP0009764_decreased_sensitivity_to | 2.03250221 |
| 33 | MP0005083_abnormal_biliary_tract | 2.00968164 |
| 34 | MP0002102_abnormal_ear_morphology | 1.98737510 |
| 35 | MP0005365_abnormal_bile_salt | 1.91912608 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.84910828 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.83499660 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.74507833 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.74431043 |
| 40 | MP0008932_abnormal_embryonic_tissue | 1.71349424 |
| 41 | MP0003121_genomic_imprinting | 1.70342997 |
| 42 | MP0005499_abnormal_olfactory_system | 1.70263348 |
| 43 | MP0005394_taste/olfaction_phenotype | 1.70263348 |
| 44 | MP0005253_abnormal_eye_physiology | 1.68614876 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.67715963 |
| 46 | MP0000343_altered_response_to | 1.66809148 |
| 47 | MP0008469_abnormal_protein_level | 1.66641336 |
| 48 | MP0001853_heart_inflammation | 1.65717100 |
| 49 | MP0003718_maternal_effect | 1.65173750 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.64255840 |
| 51 | MP0009840_abnormal_foam_cell | 1.63180801 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.62223326 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.60761532 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.57354698 |
| 55 | MP0008995_early_reproductive_senescence | 1.56570957 |
| 56 | MP0001984_abnormal_olfaction | 1.55918744 |
| 57 | MP0001293_anophthalmia | 1.55713495 |
| 58 | MP0003252_abnormal_bile_duct | 1.54517873 |
| 59 | MP0000858_altered_metastatic_potential | 1.53750138 |
| 60 | MP0005387_immune_system_phenotype | 1.53520884 |
| 61 | MP0001790_abnormal_immune_system | 1.53520884 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.53495007 |
| 63 | MP0005332_abnormal_amino_acid | 1.51059590 |
| 64 | MP0000685_abnormal_immune_system | 1.50022607 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.48741294 |
| 66 | MP0002723_abnormal_immune_serum | 1.46002667 |
| 67 | MP0004947_skin_inflammation | 1.45852374 |
| 68 | MP0009379_abnormal_foot_pigmentation | 1.45414913 |
| 69 | MP0003787_abnormal_imprinting | 1.40924250 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.40233880 |
| 71 | MP0003448_altered_tumor_morphology | 1.39367521 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.38268388 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.37780697 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.37419557 |
| 75 | MP0000516_abnormal_urinary_system | 1.36083902 |
| 76 | MP0005367_renal/urinary_system_phenotyp | 1.36083902 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.35543046 |
| 78 | MP0004510_myositis | 1.35229644 |
| 79 | MP0006054_spinal_hemorrhage | 1.33206556 |
| 80 | MP0002405_respiratory_system_inflammati | 1.33035525 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 1.32937242 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 1.32707644 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 1.32508132 |
| 84 | MP0002090_abnormal_vision | 1.28537252 |
| 85 | MP0002233_abnormal_nose_morphology | 1.28502517 |
| 86 | MP0005164_abnormal_response_to | 1.28217439 |
| 87 | MP0001800_abnormal_humoral_immune | 1.25301708 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 1.23751939 |
| 89 | MP0002160_abnormal_reproductive_system | 1.23352710 |
| 90 | MP0003567_abnormal_fetal_cardiomyocyte | 1.22710069 |
| 91 | MP0001819_abnormal_immune_cell | 1.20864322 |
| 92 | MP0009763_increased_sensitivity_to | 1.19303845 |
| 93 | MP0005166_decreased_susceptibility_to | 1.18901353 |
| 94 | MP0009643_abnormal_urine_homeostasis | 1.18700808 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.18684021 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 1.18187271 |
| 97 | MP0004215_abnormal_myocardial_fiber | 1.18014577 |
| 98 | MP0002751_abnormal_autonomic_nervous | 1.17730431 |
| 99 | MP0003077_abnormal_cell_cycle | 1.17582183 |
| 100 | MP0002420_abnormal_adaptive_immunity | 1.17420779 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 1.17229931 |
| 102 | MP0003315_abnormal_perineum_morphology | 1.17144004 |
| 103 | MP0005671_abnormal_response_to | 1.14836914 |
| 104 | MP0008057_abnormal_DNA_replication | 1.14752726 |
| 105 | MP0010386_abnormal_urinary_bladder | 1.14692286 |
| 106 | MP0000609_abnormal_liver_physiology | 1.12314075 |
| 107 | MP0003075_altered_response_to | 1.12045098 |
| 108 | MP0002638_abnormal_pupillary_reflex | 1.11802426 |
| 109 | MP0003300_gastrointestinal_ulcer | 1.10152691 |
| 110 | MP0005023_abnormal_wound_healing | 1.10028660 |
| 111 | MP0005379_endocrine/exocrine_gland_phen | 1.09833786 |
| 112 | MP0003786_premature_aging | 1.09797819 |
| 113 | MP0002282_abnormal_trachea_morphology | 1.08988209 |
| 114 | MP0003693_abnormal_embryo_hatching | 1.08653163 |
| 115 | MP0003566_abnormal_cell_adhesion | 1.08307088 |
| 116 | MP0010329_abnormal_lipoprotein_level | 1.07975286 |
| 117 | MP0003111_abnormal_nucleus_morphology | 1.07511840 |
| 118 | MP0000604_amyloidosis | 1.07372951 |
| 119 | MP0001958_emphysema | 1.05591887 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05353394 |
| 121 | MP0008007_abnormal_cellular_replicative | 1.02085745 |
| 122 | MP0005187_abnormal_penis_morphology | 1.01856523 |
| 123 | MP0002136_abnormal_kidney_physiology | 1.01768139 |
| 124 | MP0003011_delayed_dark_adaptation | 1.00470210 |
| 125 | MP0005408_hypopigmentation | 1.00279401 |
| 126 | MP0005390_skeleton_phenotype | 0.99486159 |
| 127 | MP0005391_vision/eye_phenotype | 0.99364436 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.99120052 |
| 129 | MP0000631_abnormal_neuroendocrine_gland | 0.98966232 |
| 130 | MP0000358_abnormal_cell_content/ | 0.97458956 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.96740159 |
| 132 | MP0000647_abnormal_sebaceous_gland | 0.95895740 |
| 133 | MP0001542_abnormal_bone_strength | 0.95735967 |
| 134 | MP0003172_abnormal_lysosome_physiology | 0.94482936 |
| 135 | MP0002736_abnormal_nociception_after | 0.94267585 |
| 136 | MP0002095_abnormal_skin_pigmentation | 0.93155241 |
| 137 | MP0004133_heterotaxia | 0.92689718 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.92382143 |
| 139 | MP0005645_abnormal_hypothalamus_physiol | 0.92308795 |
| 140 | MP0005248_abnormal_Harderian_gland | 0.91926035 |
| 141 | MP0003937_abnormal_limbs/digits/tail_de | 0.91593077 |
| 142 | MP0003283_abnormal_digestive_organ | 0.91073654 |
| 143 | MP0000598_abnormal_liver_morphology | 0.90912034 |
| 144 | MP0002163_abnormal_gland_morphology | 0.90456327 |
| 145 | MP0009697_abnormal_copulation | 0.89568581 |
| 146 | MP0008004_abnormal_stomach_pH | 0.89179147 |
| 147 | MP0005171_absent_coat_pigmentation | 0.88771975 |
| 148 | MP0005636_abnormal_mineral_homeostasis | 0.88512687 |
| 149 | MP0004142_abnormal_muscle_tone | 0.87870785 |
| 150 | MP0001666_abnormal_nutrient_absorption | 0.87455641 |
| 151 | MP0002933_joint_inflammation | 0.87287152 |
| 152 | MP0010030_abnormal_orbit_morphology | 0.86435048 |
| 153 | MP0005275_abnormal_skin_tensile | 0.86228322 |
| 154 | MP0003453_abnormal_keratinocyte_physiol | 0.85212579 |
| 155 | MP0003279_aneurysm | 0.85200392 |
| 156 | MP0001286_abnormal_eye_development | 0.83976310 |
| 157 | MP0004145_abnormal_muscle_electrophysio | 0.82825921 |
| 158 | MP0010307_abnormal_tumor_latency | 0.81666313 |
| 159 | MP0002295_abnormal_pulmonary_circulatio | 0.81037705 |
| 160 | MP0001756_abnormal_urination | 0.80593158 |
| 161 | MP0000778_abnormal_nervous_system | 0.78476140 |
| 162 | MP0003795_abnormal_bone_structure | 0.77681136 |
| 163 | MP0002006_tumorigenesis | 0.77517224 |
| 164 | MP0005451_abnormal_body_composition | 0.77479467 |
| 165 | MP0002876_abnormal_thyroid_physiology | 0.77442417 |
| 166 | MP0000249_abnormal_blood_vessel | 0.76562752 |
| 167 | MP0003091_abnormal_cell_migration | 0.76470239 |
| 168 | MP0003941_abnormal_skin_development | 0.76067064 |
| 169 | MP0005174_abnormal_tail_pigmentation | 0.76003637 |
| 170 | MP0000653_abnormal_sex_gland | 0.74672280 |
| 171 | MP0001764_abnormal_homeostasis | 0.74197824 |
| 172 | MP0008873_increased_physiological_sensi | 0.73985695 |
| 173 | MP0001324_abnormal_eye_pigmentation | 0.73678747 |
| 174 | MP0003755_abnormal_palate_morphology | 0.73667705 |
| 175 | MP0005195_abnormal_posterior_eye | 0.73528799 |
| 176 | MP0001243_abnormal_dermal_layer | 0.73496799 |
| 177 | MP0003385_abnormal_body_wall | 0.72927726 |
| 178 | MP0000716_abnormal_immune_system | 0.72886960 |
| 179 | MP0002210_abnormal_sex_determination | 0.71881818 |
| 180 | MP0002118_abnormal_lipid_homeostasis | 0.71486027 |
| 181 | MP0002332_abnormal_exercise_endurance | 0.71379190 |
| 182 | MP0005397_hematopoietic_system_phenotyp | 0.71365132 |
| 183 | MP0001929_abnormal_gametogenesis | 0.71194122 |
| 184 | MP0005389_reproductive_system_phenotype | 0.70611424 |
| 185 | MP0009046_muscle_twitch | 0.67853114 |
| 186 | MP0004134_abnormal_chest_morphology | 0.67468922 |
| 187 | MP0008872_abnormal_physiological_respon | 0.67448101 |
| 188 | MP0000049_abnormal_middle_ear | 0.67107571 |
| 189 | MP0001119_abnormal_female_reproductive | 0.66947738 |
| 190 | MP0001145_abnormal_male_reproductive | 0.66327331 |
| 191 | MP0001905_abnormal_dopamine_level | 0.65182866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.66226357 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.44976678 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.87175590 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.84199221 |
| 5 | Acute encephalopathy (HP:0006846) | 4.63928371 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.63122609 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.45168634 |
| 8 | Mitochondrial inheritance (HP:0001427) | 4.28932835 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.20029379 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.14636792 |
| 11 | Hepatocellular necrosis (HP:0001404) | 4.10201010 |
| 12 | Hepatic necrosis (HP:0002605) | 4.01760912 |
| 13 | Increased CSF lactate (HP:0002490) | 4.01122872 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.99818417 |
| 15 | Increased hepatocellular lipid droplets (HP:0006565) | 3.69148322 |
| 16 | Axonal loss (HP:0003447) | 3.63390699 |
| 17 | Increased serum pyruvate (HP:0003542) | 3.54562227 |
| 18 | Lipid accumulation in hepatocytes (HP:0006561) | 3.50142694 |
| 19 | Cerebral edema (HP:0002181) | 3.46584755 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.46319633 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.26011249 |
| 22 | Hyperglycinemia (HP:0002154) | 3.25697987 |
| 23 | Abnormality of glycolysis (HP:0004366) | 3.25520139 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23038318 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.22960824 |
| 26 | Vertebral compression fractures (HP:0002953) | 3.19029433 |
| 27 | 3-Methylglutaconic aciduria (HP:0003535) | 3.17117238 |
| 28 | Medial flaring of the eyebrow (HP:0010747) | 3.15031539 |
| 29 | Xanthomatosis (HP:0000991) | 3.14082859 |
| 30 | Myocardial infarction (HP:0001658) | 3.11957786 |
| 31 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.10935346 |
| 32 | Renal Fanconi syndrome (HP:0001994) | 3.07503386 |
| 33 | Tetraparesis (HP:0002273) | 2.99951102 |
| 34 | Nausea (HP:0002018) | 2.99461965 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.98470208 |
| 36 | Colon cancer (HP:0003003) | 2.94907532 |
| 37 | Joint hemorrhage (HP:0005261) | 2.94689130 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.93430197 |
| 39 | Lactic acidosis (HP:0003128) | 2.89627108 |
| 40 | Increased serum lactate (HP:0002151) | 2.89038275 |
| 41 | Gingivitis (HP:0000230) | 2.88284872 |
| 42 | Congenital primary aphakia (HP:0007707) | 2.87892755 |
| 43 | Recurrent skin infections (HP:0001581) | 2.84711402 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.80094654 |
| 45 | Pancreatic fibrosis (HP:0100732) | 2.76878007 |
| 46 | True hermaphroditism (HP:0010459) | 2.76067560 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.75692133 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.75563477 |
| 49 | Gait imbalance (HP:0002141) | 2.75008715 |
| 50 | Type I transferrin isoform profile (HP:0003642) | 2.71198678 |
| 51 | Stomatitis (HP:0010280) | 2.68773297 |
| 52 | Respiratory failure (HP:0002878) | 2.66477883 |
| 53 | Nephrogenic diabetes insipidus (HP:0009806) | 2.66407248 |
| 54 | Urticaria (HP:0001025) | 2.65798121 |
| 55 | Peritonitis (HP:0002586) | 2.64920032 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.61210281 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.60358200 |
| 58 | Abnormality of midbrain morphology (HP:0002418) | 2.58805935 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 2.58805935 |
| 60 | Prolonged partial thromboplastin time (HP:0003645) | 2.58032684 |
| 61 | Deep venous thrombosis (HP:0002625) | 2.54704913 |
| 62 | Reduced antithrombin III activity (HP:0001976) | 2.53630096 |
| 63 | Reticulocytopenia (HP:0001896) | 2.51259499 |
| 64 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.50904036 |
| 65 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.50904036 |
| 66 | Abnormality of proline metabolism (HP:0010907) | 2.49523019 |
| 67 | Hydroxyprolinuria (HP:0003080) | 2.49523019 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.47354374 |
| 69 | Methylmalonic acidemia (HP:0002912) | 2.46059721 |
| 70 | Optic disc pallor (HP:0000543) | 2.44895381 |
| 71 | Orchitis (HP:0100796) | 2.42969393 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40618966 |
| 73 | Obstructive lung disease (HP:0006536) | 2.40618966 |
| 74 | Abnormal protein glycosylation (HP:0012346) | 2.39103589 |
| 75 | Abnormal glycosylation (HP:0012345) | 2.39103589 |
| 76 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39103589 |
| 77 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.39103589 |
| 78 | Interstitial pulmonary disease (HP:0006530) | 2.36511352 |
| 79 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36386650 |
| 80 | Exercise intolerance (HP:0003546) | 2.35419066 |
| 81 | Macrocytic anemia (HP:0001972) | 2.34941190 |
| 82 | Myositis (HP:0100614) | 2.34483315 |
| 83 | Lethargy (HP:0001254) | 2.33790156 |
| 84 | Increased serum ferritin (HP:0003281) | 2.33163428 |
| 85 | Leukodystrophy (HP:0002415) | 2.32463549 |
| 86 | Exertional dyspnea (HP:0002875) | 2.32020430 |
| 87 | Pancreatic cysts (HP:0001737) | 2.30816840 |
| 88 | Hypobetalipoproteinemia (HP:0003563) | 2.30814648 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.30549700 |
| 90 | Glomerulonephritis (HP:0000099) | 2.27713618 |
| 91 | Abnormality of complement system (HP:0005339) | 2.27006624 |
| 92 | Abnormality of serum amino acid levels (HP:0003112) | 2.26984700 |
| 93 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.26274990 |
| 94 | Poor head control (HP:0002421) | 2.25542446 |
| 95 | Genital tract atresia (HP:0001827) | 2.25118953 |
| 96 | Nephronophthisis (HP:0000090) | 2.25044602 |
| 97 | CNS demyelination (HP:0007305) | 2.24261107 |
| 98 | Degeneration of anterior horn cells (HP:0002398) | 2.23877310 |
| 99 | Abnormality of the anterior horn cell (HP:0006802) | 2.23877310 |
| 100 | Osteolytic defects of the hand bones (HP:0009699) | 2.23452227 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.23452227 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.22102535 |
| 103 | Pathologic fracture (HP:0002756) | 2.20858173 |
| 104 | Hypoglycemic coma (HP:0001325) | 2.20578075 |
| 105 | Short tibia (HP:0005736) | 2.20370149 |
| 106 | Esophageal varix (HP:0002040) | 2.19465537 |
| 107 | Premature rupture of membranes (HP:0001788) | 2.19199917 |
| 108 | Vaginal atresia (HP:0000148) | 2.17948421 |
| 109 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17592234 |
| 110 | Abnormality of glycine metabolism (HP:0010895) | 2.17592234 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 2.16112769 |
| 112 | Hyperglycinuria (HP:0003108) | 2.15479839 |
| 113 | Neoplasm of the adrenal gland (HP:0100631) | 2.14908203 |
| 114 | Abnormal hemoglobin (HP:0011902) | 2.14465218 |
| 115 | Basal ganglia calcification (HP:0002135) | 2.12988591 |
| 116 | Pustule (HP:0200039) | 2.12935608 |
| 117 | Abnormal number of erythroid precursors (HP:0012131) | 2.12742472 |
| 118 | Increased IgM level (HP:0003496) | 2.11841688 |
| 119 | Abnormality of the labia minora (HP:0012880) | 2.10333305 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09701775 |
| 121 | Mucopolysacchariduria (HP:0008155) | 2.09701775 |
| 122 | Hepatosplenomegaly (HP:0001433) | 2.09519467 |
| 123 | Bile duct proliferation (HP:0001408) | 2.09323882 |
| 124 | Abnormal biliary tract physiology (HP:0012439) | 2.09323882 |
| 125 | Fat malabsorption (HP:0002630) | 2.09020353 |
| 126 | Proximal tubulopathy (HP:0000114) | 2.08775394 |
| 127 | Hypercholesterolemia (HP:0003124) | 2.06515800 |
| 128 | Recurrent fungal infections (HP:0002841) | 2.06257286 |
| 129 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.05773131 |
| 130 | Complement deficiency (HP:0004431) | 2.05632207 |
| 131 | Microvesicular hepatic steatosis (HP:0001414) | 2.03687842 |
| 132 | Abnormality of renal resorption (HP:0011038) | 2.01009536 |
| 133 | Generalized aminoaciduria (HP:0002909) | 2.00646917 |
| 134 | Gingival bleeding (HP:0000225) | 2.00511056 |
| 135 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00226699 |
| 136 | Periodontitis (HP:0000704) | 2.00116516 |
| 137 | Bifid tongue (HP:0010297) | 1.99909839 |
| 138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99401676 |
| 139 | Vasculitis (HP:0002633) | 1.98861049 |
| 140 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98285567 |
| 141 | Menorrhagia (HP:0000132) | 1.97166497 |
| 142 | Renal cortical cysts (HP:0000803) | 1.97049889 |
| 143 | Bone pain (HP:0002653) | 1.96954015 |
| 144 | Purpura (HP:0000979) | 1.96088030 |
| 145 | Vascular calcification (HP:0004934) | 1.95337031 |
| 146 | Nephritis (HP:0000123) | 1.95118659 |
| 147 | Esophageal neoplasm (HP:0100751) | 1.94421400 |
| 148 | Neoplasm of head and neck (HP:0012288) | 1.94421400 |
| 149 | Beaking of vertebral bodies (HP:0004568) | 1.93523624 |
| 150 | Tubulointerstitial nephritis (HP:0001970) | 1.92555226 |
| 151 | Glycosuria (HP:0003076) | 1.92519098 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.92519098 |
| 153 | Intestinal atresia (HP:0011100) | 1.92502652 |
| 154 | Hypothermia (HP:0002045) | 1.92385903 |
| 155 | Cardiovascular calcification (HP:0011915) | 1.92002998 |
| 156 | Hypolipoproteinemia (HP:0010981) | 1.91878104 |
| 157 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91722290 |
| 158 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.91341543 |
| 159 | Steatorrhea (HP:0002570) | 1.90962421 |
| 160 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.90737526 |
| 161 | Dicarboxylic aciduria (HP:0003215) | 1.90737526 |
| 162 | Increased muscle lipid content (HP:0009058) | 1.89132212 |
| 163 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.89131987 |
| 164 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88219114 |
| 165 | Hepatocellular carcinoma (HP:0001402) | 1.87925343 |
| 166 | Mucosal telangiectasiae (HP:0100579) | 1.87706910 |
| 167 | Disinhibition (HP:0000734) | 1.86836649 |
| 168 | Emotional lability (HP:0000712) | 1.86265647 |
| 169 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.86033806 |
| 170 | Optic neuritis (HP:0100653) | 1.85299651 |
| 171 | Retrobulbar optic neuritis (HP:0100654) | 1.85299651 |
| 172 | Cellulitis (HP:0100658) | 1.85293599 |
| 173 | Osteomyelitis (HP:0002754) | 1.83783925 |
| 174 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83559519 |
| 175 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83317196 |
| 176 | Sclerocornea (HP:0000647) | 1.83030945 |
| 177 | Supernumerary spleens (HP:0009799) | 1.82989837 |
| 178 | Methylmalonic aciduria (HP:0012120) | 1.82973482 |
| 179 | Triphalangeal thumb (HP:0001199) | 1.82963013 |
| 180 | Mitral stenosis (HP:0001718) | 1.82719545 |
| 181 | Multiple enchondromatosis (HP:0005701) | 1.81989444 |
| 182 | Abnormal cartilage morphology (HP:0002763) | 1.81233255 |
| 183 | Protrusio acetabuli (HP:0003179) | 1.81131235 |
| 184 | Poor coordination (HP:0002370) | 1.80561340 |
| 185 | Joint swelling (HP:0001386) | 1.79983631 |
| 186 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.79475756 |
| 187 | Volvulus (HP:0002580) | 1.79096234 |
| 188 | Hypoglycemic seizures (HP:0002173) | 1.78895418 |
| 189 | Decreased testicular size (HP:0008734) | 1.78713789 |
| 190 | Hyperphosphaturia (HP:0003109) | 1.76839885 |
| 191 | Abnormality of the renal medulla (HP:0100957) | 1.75081273 |
| 192 | Postaxial foot polydactyly (HP:0001830) | 1.74934366 |
| 193 | Respiratory difficulties (HP:0002880) | 1.74491692 |
| 194 | Median cleft lip (HP:0000161) | 1.73885040 |
| 195 | Broad foot (HP:0001769) | 1.73146197 |
| 196 | Male pseudohermaphroditism (HP:0000037) | 1.72130651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.91277722 |
| 2 | NME2 | 3.76686736 |
| 3 | MAP3K14 | 3.19481023 |
| 4 | TBK1 | 3.15560606 |
| 5 | VRK2 | 3.14254818 |
| 6 | MAP4K2 | 2.95372160 |
| 7 | PIM2 | 2.82238114 |
| 8 | NEK1 | 2.68683339 |
| 9 | ERN1 | 2.65282916 |
| 10 | MST1R | 2.64573335 |
| 11 | STK16 | 2.55632574 |
| 12 | IRAK3 | 2.48665864 |
| 13 | NUAK1 | 2.37611063 |
| 14 | BUB1 | 2.36547481 |
| 15 | TESK1 | 2.36384601 |
| 16 | RIPK4 | 2.23031573 |
| 17 | NEK9 | 2.18133229 |
| 18 | ZAK | 2.17168967 |
| 19 | VRK1 | 2.14677032 |
| 20 | WNK3 | 2.14438431 |
| 21 | BLK | 2.13930933 |
| 22 | MAP3K12 | 2.12928155 |
| 23 | ABL2 | 2.05418870 |
| 24 | TYK2 | 2.01914306 |
| 25 | TRIM28 | 1.96388019 |
| 26 | RPS6KA4 | 1.95736871 |
| 27 | PLK3 | 1.91660298 |
| 28 | EIF2AK1 | 1.91330094 |
| 29 | MKNK1 | 1.89375301 |
| 30 | PLK4 | 1.89292157 |
| 31 | WEE1 | 1.83795220 |
| 32 | SRPK1 | 1.80105960 |
| 33 | IKBKE | 1.77097675 |
| 34 | IRAK4 | 1.74034453 |
| 35 | ERBB4 | 1.72013230 |
| 36 | IKBKB | 1.66487349 |
| 37 | LIMK1 | 1.53599580 |
| 38 | MAP3K4 | 1.52803903 |
| 39 | MST4 | 1.51463251 |
| 40 | MAP3K11 | 1.45152871 |
| 41 | JAK3 | 1.43900566 |
| 42 | TRPM7 | 1.42258446 |
| 43 | CSNK1G3 | 1.40164519 |
| 44 | CDC7 | 1.36006428 |
| 45 | CSNK1G1 | 1.31224871 |
| 46 | TNIK | 1.30478188 |
| 47 | PIK3CG | 1.29407643 |
| 48 | CCNB1 | 1.28541302 |
| 49 | CDK19 | 1.27190039 |
| 50 | ERBB3 | 1.25978114 |
| 51 | PLK2 | 1.21681082 |
| 52 | MAP3K3 | 1.21576008 |
| 53 | KIT | 1.21296899 |
| 54 | CSNK1G2 | 1.21015669 |
| 55 | TESK2 | 1.19659184 |
| 56 | BMX | 1.19339778 |
| 57 | DYRK3 | 1.16701224 |
| 58 | DYRK2 | 1.14663611 |
| 59 | PLK1 | 1.13432118 |
| 60 | TTK | 1.12210871 |
| 61 | CSNK1A1L | 1.11637210 |
| 62 | JAK1 | 1.10804187 |
| 63 | TAF1 | 1.10215305 |
| 64 | KDR | 1.09600413 |
| 65 | PINK1 | 1.08506885 |
| 66 | CASK | 1.08026223 |
| 67 | CSK | 1.06973600 |
| 68 | TXK | 1.06575647 |
| 69 | MKNK2 | 1.05788882 |
| 70 | BRSK2 | 1.04445506 |
| 71 | LRRK2 | 1.03808991 |
| 72 | CDK8 | 0.99674675 |
| 73 | TTN | 0.98998243 |
| 74 | INSRR | 0.98744191 |
| 75 | STK4 | 0.95723109 |
| 76 | MET | 0.94730084 |
| 77 | FLT3 | 0.93661241 |
| 78 | MAPK13 | 0.93225831 |
| 79 | MAP3K5 | 0.93187225 |
| 80 | TSSK6 | 0.93096476 |
| 81 | EIF2AK3 | 0.91260351 |
| 82 | MAP2K7 | 0.90778236 |
| 83 | FGFR4 | 0.89788172 |
| 84 | CHUK | 0.89614840 |
| 85 | MAP2K3 | 0.89391319 |
| 86 | PASK | 0.89244138 |
| 87 | BCKDK | 0.88799490 |
| 88 | GRK1 | 0.86535945 |
| 89 | PIM1 | 0.84560488 |
| 90 | AURKB | 0.84390704 |
| 91 | EPHA2 | 0.82071877 |
| 92 | MOS | 0.81829932 |
| 93 | FRK | 0.81245083 |
| 94 | ZAP70 | 0.78710407 |
| 95 | TAOK2 | 0.78379369 |
| 96 | ARAF | 0.75803257 |
| 97 | PNCK | 0.74806979 |
| 98 | LYN | 0.73846412 |
| 99 | ILK | 0.71771790 |
| 100 | TAOK3 | 0.70071090 |
| 101 | ADRBK2 | 0.69819645 |
| 102 | TIE1 | 0.69367063 |
| 103 | DAPK3 | 0.68298723 |
| 104 | EIF2AK2 | 0.67968391 |
| 105 | TRIB3 | 0.67675861 |
| 106 | ATR | 0.66430529 |
| 107 | MUSK | 0.66346638 |
| 108 | PRKG2 | 0.64268847 |
| 109 | CHEK2 | 0.63572867 |
| 110 | DAPK1 | 0.63461842 |
| 111 | MINK1 | 0.63425782 |
| 112 | PRKCD | 0.62633687 |
| 113 | STK10 | 0.62133386 |
| 114 | CSNK2A2 | 0.62021546 |
| 115 | EGFR | 0.60628492 |
| 116 | PRKCE | 0.59751483 |
| 117 | MYLK | 0.59531824 |
| 118 | STK39 | 0.58983011 |
| 119 | MARK3 | 0.58488950 |
| 120 | SCYL2 | 0.58231845 |
| 121 | MAPKAPK5 | 0.57934361 |
| 122 | JAK2 | 0.56813685 |
| 123 | CSNK2A1 | 0.56355801 |
| 124 | ABL1 | 0.54901204 |
| 125 | ATM | 0.53865702 |
| 126 | PAK3 | 0.53773289 |
| 127 | TGFBR1 | 0.53424471 |
| 128 | STK3 | 0.53149014 |
| 129 | PDK2 | 0.53121498 |
| 130 | PTK6 | 0.52767167 |
| 131 | HCK | 0.51657728 |
| 132 | MATK | 0.51396944 |
| 133 | IRAK2 | 0.51391761 |
| 134 | EPHB1 | 0.51236742 |
| 135 | MAP3K13 | 0.51068035 |
| 136 | BMPR1B | 0.51023100 |
| 137 | SYK | 0.49731726 |
| 138 | MAP4K1 | 0.49583302 |
| 139 | PAK4 | 0.49456982 |
| 140 | MAP2K1 | 0.48763375 |
| 141 | DDR2 | 0.48610150 |
| 142 | LCK | 0.48315122 |
| 143 | TEC | 0.48207227 |
| 144 | PKN2 | 0.47879358 |
| 145 | FGR | 0.47835313 |
| 146 | IRAK1 | 0.47736585 |
| 147 | BMPR2 | 0.46940814 |
| 148 | ACVR1B | 0.46245518 |
| 149 | EPHA4 | 0.46138281 |
| 150 | CSF1R | 0.45944855 |
| 151 | TLK1 | 0.45773272 |
| 152 | MAP3K8 | 0.45647531 |
| 153 | TGFBR2 | 0.44046590 |
| 154 | PIK3CA | 0.43820531 |
| 155 | EPHA3 | 0.43471714 |
| 156 | PRKCG | 0.43104746 |
| 157 | RPS6KA5 | 0.42916892 |
| 158 | OBSCN | 0.42800017 |
| 159 | BCR | 0.42200429 |
| 160 | NME1 | 0.42185530 |
| 161 | CDK14 | 0.41105290 |
| 162 | CDK3 | 0.40441082 |
| 163 | BTK | 0.39422900 |
| 164 | PTK2 | 0.39182823 |
| 165 | WNK4 | 0.38807981 |
| 166 | CDK6 | 0.38732893 |
| 167 | NEK2 | 0.38635901 |
| 168 | EPHB2 | 0.36293701 |
| 169 | STK38L | 0.35409967 |
| 170 | CAMK2D | 0.34719887 |
| 171 | PHKG2 | 0.33810858 |
| 172 | PHKG1 | 0.33810858 |
| 173 | OXSR1 | 0.32468403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.72344837 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60576201 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32750274 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.31070627 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.28875373 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.27016849 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24452200 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.24427409 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.23098798 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.12359891 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.10461676 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.09758747 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.06356561 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.99154028 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 1.99130605 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 1.97299673 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.95867130 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.88837669 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.87738602 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.79915780 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.79715862 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79171854 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78491790 |
| 24 | Homologous recombination_Homo sapiens_hsa03440 | 1.78448801 |
| 25 | Phagosome_Homo sapiens_hsa04145 | 1.77623182 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.75436214 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74528388 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73759977 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.73337225 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.65094531 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64168965 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62586288 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.62197501 |
| 34 | Lysosome_Homo sapiens_hsa04142 | 1.55109526 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51602198 |
| 36 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.50591154 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.48454858 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.47475440 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47250019 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.44914523 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.44878465 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.44819359 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.44666419 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43216485 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.41885352 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39621367 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38730956 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.38363128 |
| 49 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.37337045 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36333099 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.35232629 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33711765 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33632851 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 1.32956551 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32549059 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31410476 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30351036 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 1.29730499 |
| 59 | Asthma_Homo sapiens_hsa05310 | 1.27428514 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.23002763 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22677101 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22190062 |
| 63 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16453018 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16396962 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16160197 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14932225 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13945265 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09274001 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05871934 |
| 70 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05752972 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 1.04081212 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03342990 |
| 73 | Measles_Homo sapiens_hsa05162 | 1.02878593 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.02743001 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.99938677 |
| 76 | Influenza A_Homo sapiens_hsa05164 | 0.99855727 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99636753 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.98352565 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.98044801 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97966605 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97779247 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97011513 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93554488 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.91087358 |
| 85 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90246581 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89932431 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89602077 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89548907 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88300189 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85687973 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.85094522 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.84977763 |
| 93 | Cell cycle_Homo sapiens_hsa04110 | 0.84465154 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84188614 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82800520 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80747548 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79691915 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78498028 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78301420 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77774727 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77602866 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76779421 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75948044 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74956034 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73483152 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72136733 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69685912 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69345734 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.68886353 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68866958 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68111177 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66894728 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.66754797 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66362803 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63613436 |
| 116 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.63379505 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62079613 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.61681293 |
| 119 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61034260 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.60440046 |
| 121 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60373283 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.57715963 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57475746 |
| 124 | Ribosome_Homo sapiens_hsa03010 | 0.57286599 |
| 125 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56299453 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55935613 |
| 127 | Phototransduction_Homo sapiens_hsa04744 | 0.53590663 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52023766 |
| 129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51089038 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49846621 |
| 131 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49844373 |
| 132 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49830368 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49797841 |
| 134 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49736614 |
| 135 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.49622638 |
| 136 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.48209935 |
| 137 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44638490 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44359478 |
| 139 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43887472 |
| 140 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.40374465 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35096284 |
| 142 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34965936 |
| 143 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29087919 |
| 144 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25030556 |
| 145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24354553 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24153636 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22856145 |
| 148 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21812936 |
| 149 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.18800011 |
| 150 | Alcoholism_Homo sapiens_hsa05034 | 0.15645604 |
| 151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14958598 |
| 152 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12104770 |

